Members of Local 110 Demand Fair Contract, Affordable Health Care EBENSBURG, Pa., Oct. 23, 2026 -- Members of Teamsters Local 110 at two Abarta Coca-Cola facilities in Dubois and Ebensburg, Pa., have been forced to the picket line after months of negotiations. The 85...
Real-world analysis showed serum phosphate reductions following XPHOZAH initiation across all phosphate binder groups evaluated
>90% free APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval
SAN JUAN CAPISTRANO, Calif., Oct. 23, 2026 -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it expects to issue its third quarter 2026 financial results on Tuesday, October 27, 2026.
NEW YORK, Oct. 23, 2026 -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8:30 am Eastern Time on October 30, 2026, to discuss the company’s financial results for the third quarter ended September 30, 2026. A news release containing the results will be issued before the open of the U.S. equity markets and will be available on http://ir.silvercrestgroup.com/.
CHATTANOOGA, Tenn., Oct. 23, 2026 -- You are invited by Astec Industries, Inc. (NASDAQ: ASTE) to participate in a conference call to review the company’s third quarter 2026 financial results.
October 7 ribbon cutting brings together company owners, local officials, and Lebanon's business community LEBANON, Pa., Oct. 23, 2026 -- AllDayShirts celebrated the official opening of its 92,000-square-foot flagship warehouse in Lebanon, Pennsylvania, with a...
Free, virtual meeting on March 16, 2027 will gather patient and care partner testimony on life with MSA to inform future treatments. CHICAGO, Oct. 23, 2026 -- Mission MSA, a nonprofit supporting people affected by multiple system atrophy (MSA), will host a virtual...
HILLSBOROUGH, N.C., Oct. 23, 2026 -- Leland Little Auctions is pleased to announce the opening of their Charleston, South Carolina location, solidifying their presence in the Lowcountry, and providing dedicated service to their clients throughout the region. Working in...
ATLANTA, Oct. 23, 2026 -- MetroCity Bankshares, Inc. ("MetroCity" or the "Company") (NASDAQ: MCBS), holding company for Metro City Bank (the "Bank"), today reported net income of $24.3 million, or $0.84 per diluted share, for the third quarter of 2026, compared to $22.1...
SPYR Completes Change of Control with Ledjr AI
NEWTOWN SQUARE, Pa., Oct. 23, 2026 -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that initial safety and efficacy data from the Phase 1 (NCT07066657) study of CDH17-targeted ADC ARR-217 (MRG007) in patients with gastrointestinal cancers, will be presented in a rapid oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026 taking place in Madrid, Spain, on October 23-27, 2026. ArriVent plans to host a virtual webinar on October 26, 2026 at 8 am ET to discuss the data and ARR-217 program. To register for the event, click here.